Logo image of IOSP

INNOSPEC INC (IOSP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IOSP - US45768S1050 - Common Stock

74.95 USD
-0.09 (-0.12%)
Last: 12/8/2025, 8:18:39 PM
74.95 USD
0 (0%)
After Hours: 12/8/2025, 8:18:39 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IOSP. IOSP was compared to 82 industry peers in the Chemicals industry. IOSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IOSP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

IOSP had positive earnings in the past year.
IOSP had a positive operating cash flow in the past year.
Each year in the past 5 years IOSP has been profitable.
IOSP had a positive operating cash flow in each of the past 5 years.
IOSP Yearly Net Income VS EBIT VS OCF VS FCFIOSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -0.07%, IOSP perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
IOSP has a Return On Equity of -0.09%. This is comparable to the rest of the industry: IOSP outperforms 54.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.58%, IOSP belongs to the top of the industry, outperforming 81.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IOSP is significantly above the industry average of 6.05%.
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROIC 9.58%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
IOSP Yearly ROA, ROE, ROICIOSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IOSP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.31%, IOSP is in line with its industry, outperforming 53.66% of the companies in the same industry.
IOSP's Operating Margin has been stable in the last couple of years.
IOSP's Gross Margin of 28.01% is in line compared to the rest of the industry. IOSP outperforms 52.44% of its industry peers.
IOSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.31%
PM (TTM) N/A
GM 28.01%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
IOSP Yearly Profit, Operating, Gross MarginsIOSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IOSP is creating some value.
Compared to 1 year ago, IOSP has more shares outstanding
IOSP has more shares outstanding than it did 5 years ago.
There is no outstanding debt for IOSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IOSP Yearly Shares OutstandingIOSP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IOSP Yearly Total Debt VS Total AssetsIOSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.78 indicates that IOSP is not in any danger for bankruptcy at the moment.
The Altman-Z score of IOSP (4.78) is better than 92.68% of its industry peers.
There is no outstanding debt for IOSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.78
ROIC/WACC1.09
WACC8.78%
IOSP Yearly LT Debt VS Equity VS FCFIOSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.78 indicates that IOSP has no problem at all paying its short term obligations.
IOSP has a better Current ratio (2.78) than 78.05% of its industry peers.
A Quick Ratio of 1.81 indicates that IOSP should not have too much problems paying its short term obligations.
The Quick ratio of IOSP (1.81) is better than 74.39% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 1.81
IOSP Yearly Current Assets VS Current LiabilitesIOSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

IOSP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.11%.
IOSP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.75% yearly.
The Revenue has decreased by -4.49% in the past year.
The Revenue has been growing slightly by 4.05% on average over the past years.
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%

3.2 Future

The Earnings Per Share is expected to grow by 2.47% on average over the next years.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y-14.21%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue Next Year-2.31%
Revenue Next 2Y1.31%
Revenue Next 3Y2.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IOSP Yearly Revenue VS EstimatesIOSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
IOSP Yearly EPS VS EstimatesIOSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.11, which indicates a correct valuation of IOSP.
IOSP's Price/Earnings ratio is a bit cheaper when compared to the industry. IOSP is cheaper than 71.95% of the companies in the same industry.
IOSP is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.19, IOSP is valued correctly.
Based on the Price/Forward Earnings ratio, IOSP is valued a bit cheaper than the industry average as 63.41% of the companies are valued more expensively.
IOSP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.11
Fwd PE 13.19
IOSP Price Earnings VS Forward Price EarningsIOSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IOSP is valued a bit cheaper than 76.83% of the companies in the same industry.
IOSP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 67.54
EV/EBITDA 7.51
IOSP Per share dataIOSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.14
EPS Next 2Y-2.69%
EPS Next 3Y2.47%

5

5. Dividend

5.1 Amount

IOSP has a Yearly Dividend Yield of 2.35%.
Compared to an average industry Dividend Yield of 3.98, IOSP has a dividend in line with its industry peers.
IOSP's Dividend Yield is comparable with the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 2.35%

5.2 History

The dividend of IOSP is nicely growing with an annual growth rate of 8.78%!
IOSP has paid a dividend for at least 10 years, which is a reliable track record.
IOSP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.78%
Div Incr Years11
Div Non Decr Years11
IOSP Yearly Dividends per shareIOSP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

IOSP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
IOSP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-3383.33%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
IOSP Yearly Income VS Free CF VS DividendIOSP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

INNOSPEC INC

NASDAQ:IOSP (12/8/2025, 8:18:39 PM)

After market: 74.95 0 (0%)

74.95

-0.09 (-0.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-16 2026-02-16/amc
Inst Owners99.41%
Inst Owner Change-0.33%
Ins Owners1%
Ins Owner Change0.05%
Market Cap1.86B
Revenue(TTM)1.79B
Net Income(TTM)-1.20M
Analysts82.22
Price Target101.32 (35.18%)
Short Float %1.82%
Short Ratio2.03
Dividend
Industry RankSector Rank
Dividend Yield 2.35%
Yearly Dividend1.56
Dividend Growth(5Y)8.78%
DP-3383.33%
Div Incr Years11
Div Non Decr Years11
Ex-Date11-18 2025-11-18 (0.87)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.56%
Min EPS beat(2)-2.48%
Max EPS beat(2)3.59%
EPS beat(4)2
Avg EPS beat(4)2.06%
Min EPS beat(4)-2.48%
Max EPS beat(4)8.85%
EPS beat(8)4
Avg EPS beat(8)2.71%
EPS beat(12)6
Avg EPS beat(12)2.32%
EPS beat(16)10
Avg EPS beat(16)6.92%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-1.75%
Min Revenue beat(4)-6.47%
Max Revenue beat(4)2.28%
Revenue beat(8)2
Avg Revenue beat(8)-2.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.35%
Revenue beat(16)8
Avg Revenue beat(16)0.49%
PT rev (1m)-7.6%
PT rev (3m)-13.62%
EPS NQ rev (1m)-6.42%
EPS NQ rev (3m)-18.78%
EPS NY rev (1m)-4.78%
EPS NY rev (3m)-8.08%
Revenue NQ rev (1m)-2.63%
Revenue NQ rev (3m)-5.7%
Revenue NY rev (1m)-0.93%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 14.11
Fwd PE 13.19
P/S 1.04
P/FCF 67.54
P/OCF 18.1
P/B 1.43
P/tB 2.23
EV/EBITDA 7.51
EPS(TTM)5.31
EY7.08%
EPS(NY)5.68
Fwd EY7.58%
FCF(TTM)1.11
FCFY1.48%
OCF(TTM)4.14
OCFY5.52%
SpS72.2
BVpS52.34
TBVpS33.65
PEG (NY)N/A
PEG (5Y)5.14
Graham Number79.08
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.09%
ROCE 11.54%
ROIC 9.58%
ROICexc 11.8%
ROICexgc 19.5%
OM 9.31%
PM (TTM) N/A
GM 28.01%
FCFM 1.54%
ROA(3y)6.16%
ROA(5y)5.29%
ROE(3y)9.29%
ROE(5y)7.99%
ROIC(3y)11.29%
ROIC(5y)9.61%
ROICexc(3y)13.47%
ROICexc(5y)11.26%
ROICexgc(3y)22.5%
ROICexgc(5y)18.82%
ROCE(3y)13.59%
ROCE(5y)11.57%
ROICexgc growth 3Y13.46%
ROICexgc growth 5Y3.02%
ROICexc growth 3Y11.53%
ROICexc growth 5Y3.76%
OM growth 3Y3.11%
OM growth 5Y-0.56%
PM growth 3Y-32.51%
PM growth 5Y-23.61%
GM growth 3Y0.12%
GM growth 5Y-0.92%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 166.52%
Cap/Sales 4.2%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 1.81
Altman-Z 4.78
F-Score5
WACC8.78%
ROIC/WACC1.09
Cap/Depr(3y)148.38%
Cap/Depr(5y)120.26%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.92%
Profit Quality(3y)155.47%
Profit Quality(5y)185.88%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.11%
EPS 3Y7.65%
EPS 5Y2.75%
EPS Q2Q%-17.04%
EPS Next Y-14.21%
EPS Next 2Y-2.69%
EPS Next 3Y2.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.49%
Revenue growth 3Y7.55%
Revenue growth 5Y4.05%
Sales Q2Q%-0.34%
Revenue Next Year-2.31%
Revenue Next 2Y1.31%
Revenue Next 3Y2.57%
Revenue Next 5YN/A
EBIT growth 1Y-8.06%
EBIT growth 3Y10.9%
EBIT growth 5Y3.46%
EBIT Next Year8.35%
EBIT Next 3Y10.13%
EBIT Next 5YN/A
FCF growth 1Y-80.63%
FCF growth 3Y31.21%
FCF growth 5Y-1.32%
OCF growth 1Y-51.9%
OCF growth 3Y25.56%
OCF growth 5Y2.69%

INNOSPEC INC / IOSP FAQ

Can you provide the ChartMill fundamental rating for INNOSPEC INC?

ChartMill assigns a fundamental rating of 5 / 10 to IOSP.


Can you provide the valuation status for INNOSPEC INC?

ChartMill assigns a valuation rating of 4 / 10 to INNOSPEC INC (IOSP). This can be considered as Fairly Valued.


What is the profitability of IOSP stock?

INNOSPEC INC (IOSP) has a profitability rating of 5 / 10.


Can you provide the financial health for IOSP stock?

The financial health rating of INNOSPEC INC (IOSP) is 8 / 10.


Can you provide the expected EPS growth for IOSP stock?

The Earnings per Share (EPS) of INNOSPEC INC (IOSP) is expected to decline by -14.21% in the next year.